Annual Retained Earnings
-$4.45 B
-$535.98 M-13.71%
31 December 2023
Summary:
Sarepta Therapeutics annual retained earnings is currently -$4.45 billion, with the most recent change of -$535.98 million (-13.71%) on 31 December 2023. During the last 3 years, it has fallen by -$1.24 billion (-38.65%). SRPT annual retained earnings is now -35756.56% below its all-time high of -$12.40 million, reached on 31 December 1996.SRPT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$4.37 B
+$33.61 M+0.76%
30 September 2024
Summary:
Sarepta Therapeutics quarterly retained earnings is currently -$4.37 billion, with the most recent change of +$33.61 million (+0.76%) on 30 September 2024. Over the past year, it has increased by +$76.19 million (+1.71%). SRPT quarterly retained earnings is now -33515.56% below its all-time high of -$13.00 million, reached on 31 March 1997.SRPT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +1.7% |
| 3 y3 years | -38.6% | -36.3% |
| 5 y5 years | -93.8% | -90.5% |
SRPT Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -38.6% | at low | -36.3% | +2.7% |
| 5 y | 5 years | -93.8% | at low | -90.5% | +2.7% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +2.7% |
Sarepta Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$4.37 B(-0.8%) |
| June 2024 | - | -$4.40 B(-0.1%) |
| Mar 2024 | - | -$4.41 B(-0.8%) |
| Dec 2023 | -$4.45 B(+13.7%) | -$4.45 B(-1.0%) |
| Sept 2023 | - | -$4.49 B(+0.9%) |
| June 2023 | - | -$4.45 B(+0.5%) |
| Mar 2023 | - | -$4.43 B(+13.2%) |
| Dec 2022 | -$3.91 B(+21.9%) | -$3.91 B(+2.9%) |
| Sept 2022 | - | -$3.80 B(+7.3%) |
| June 2022 | - | -$3.54 B(+7.0%) |
| Mar 2022 | - | -$3.31 B(+3.3%) |
| Dec 2021 | -$3.21 B(+12.6%) | -$3.21 B(+4.0%) |
| Sept 2021 | - | -$3.08 B(+1.6%) |
| June 2021 | - | -$3.04 B(+2.8%) |
| Mar 2021 | - | -$2.96 B(+3.8%) |
| Dec 2020 | -$2.85 B(+24.2%) | -$2.85 B(+7.1%) |
| Sept 2020 | - | -$2.66 B(+8.0%) |
| June 2020 | - | -$2.46 B(+6.5%) |
| Mar 2020 | - | -$2.31 B(+0.8%) |
| Dec 2019 | -$2.29 B(+45.3%) | -$2.29 B(+11.5%) |
| Sept 2019 | - | -$2.06 B(+6.5%) |
| June 2019 | - | -$1.93 B(+16.7%) |
| Mar 2019 | - | -$1.66 B(+4.9%) |
| Dec 2018 | -$1.58 B(+29.7%) | -$1.58 B(+9.8%) |
| Sept 2018 | - | -$1.44 B(+5.6%) |
| June 2018 | - | -$1.36 B(+8.7%) |
| Mar 2018 | - | -$1.25 B(+2.9%) |
| Dec 2017 | -$1.22 B(+4.3%) | -$1.22 B(+2.0%) |
| Sept 2017 | - | -$1.19 B(+4.2%) |
| June 2017 | - | -$1.15 B(+5.8%) |
| Mar 2017 | - | -$1.08 B(-7.2%) |
| Dec 2016 | -$1.17 B(+29.7%) | -$1.17 B(+8.2%) |
| Sept 2016 | - | -$1.08 B(+5.6%) |
| June 2016 | - | -$1.02 B(+6.5%) |
| Mar 2016 | - | -$958.83 M(+6.6%) |
| Dec 2015 | -$899.05 M(+32.4%) | -$899.05 M(+7.8%) |
| Sept 2015 | - | -$834.37 M(+6.6%) |
| June 2015 | - | -$782.43 M(+5.7%) |
| Mar 2015 | - | -$740.58 M(+9.1%) |
| Dec 2014 | -$679.02 M(+25.0%) | -$679.02 M(+7.0%) |
| Sept 2014 | - | -$634.61 M(+4.8%) |
| June 2014 | - | -$605.38 M(+5.9%) |
| Mar 2014 | - | -$571.51 M(+5.2%) |
| Dec 2013 | -$543.24 M(+26.0%) | -$543.24 M(+1.7%) |
| Sept 2013 | - | -$534.42 M(+8.5%) |
| June 2013 | - | -$492.39 M(+4.0%) |
| Mar 2013 | - | -$473.33 M(+9.8%) |
| Dec 2012 | -$431.25 M(+39.1%) | -$431.25 M(+16.8%) |
| Sept 2012 | - | -$369.18 M(+15.5%) |
| June 2012 | - | -$319.63 M(-2.5%) |
| Mar 2012 | - | -$327.67 M(+5.7%) |
| Dec 2011 | -$309.96 M(+0.8%) | -$309.96 M(+0.5%) |
| Sept 2011 | - | -$308.55 M(+1.3%) |
| June 2011 | - | -$304.53 M(-0.4%) |
| Mar 2011 | - | -$305.81 M(-0.6%) |
| Dec 2010 | -$307.65 M | -$307.65 M(+2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | -$300.00 M(+2.5%) |
| June 2010 | - | -$292.71 M(+6.0%) |
| Mar 2010 | - | -$276.05 M(+0.2%) |
| Dec 2009 | -$275.47 M(+10.1%) | -$275.47 M(-1.3%) |
| Sept 2009 | - | -$278.99 M(+3.0%) |
| June 2009 | - | -$270.90 M(+7.8%) |
| Mar 2009 | - | -$251.24 M(+0.4%) |
| Dec 2008 | -$250.31 M(+10.6%) | -$250.31 M(+0.5%) |
| Sept 2008 | - | -$249.17 M(+2.5%) |
| June 2008 | - | -$243.12 M(+0.7%) |
| Mar 2008 | - | -$241.37 M(+6.6%) |
| Dec 2007 | -$226.36 M(+11.1%) | -$226.36 M(+1.9%) |
| Sept 2007 | - | -$222.23 M(+0.1%) |
| June 2007 | - | -$221.98 M(+4.0%) |
| Mar 2007 | - | -$213.44 M(+4.8%) |
| Dec 2006 | -$203.72 M(+18.0%) | -$203.72 M(+4.3%) |
| Sept 2006 | - | -$195.39 M(+3.6%) |
| June 2006 | - | -$188.61 M(+3.8%) |
| Mar 2006 | - | -$181.71 M(+5.2%) |
| Dec 2005 | -$172.65 M(+10.7%) | -$172.65 M(+2.7%) |
| Sept 2005 | - | -$168.10 M(+1.0%) |
| June 2005 | - | -$166.40 M(+3.1%) |
| Mar 2005 | - | -$161.47 M(+3.5%) |
| Dec 2004 | -$155.97 M(+18.9%) | -$155.97 M(+3.3%) |
| Sept 2004 | - | -$150.98 M(+3.5%) |
| June 2004 | - | -$145.88 M(+5.2%) |
| Mar 2004 | - | -$138.73 M(+5.7%) |
| Dec 2003 | -$131.19 M(+12.5%) | -$131.19 M(+2.4%) |
| Sept 2003 | - | -$128.10 M(+3.7%) |
| June 2003 | - | -$123.49 M(+2.9%) |
| Mar 2003 | - | -$120.00 M(+2.9%) |
| Dec 2002 | -$116.58 M(+33.7%) | -$116.58 M(+3.5%) |
| Sept 2002 | - | -$112.58 M(+6.7%) |
| June 2002 | - | -$105.53 M(+11.0%) |
| Mar 2002 | - | -$95.04 M(+9.0%) |
| Dec 2001 | -$87.22 M(+44.7%) | -$87.22 M(+5.6%) |
| Sept 2001 | - | -$82.61 M(+23.3%) |
| June 2001 | - | -$67.02 M(+5.6%) |
| Mar 2001 | - | -$63.47 M(+5.3%) |
| Dec 2000 | -$60.29 M(+18.0%) | -$60.29 M(+5.2%) |
| Sept 2000 | - | -$57.29 M(+4.1%) |
| June 2000 | - | -$55.03 M(+5.4%) |
| Mar 2000 | - | -$52.19 M(+2.1%) |
| Dec 1999 | -$51.10 M(+19.4%) | -$51.10 M(+4.9%) |
| Sept 1999 | - | -$48.70 M(+4.7%) |
| June 1999 | - | -$46.50 M(+4.5%) |
| Mar 1999 | - | -$44.50 M(+4.0%) |
| Dec 1998 | -$42.80 M(+167.5%) | -$42.80 M(+5.9%) |
| Sept 1998 | - | -$40.40 M(+111.5%) |
| June 1998 | - | -$19.10 M(+9.1%) |
| Mar 1998 | - | -$17.50 M(+9.4%) |
| Dec 1997 | -$16.00 M(+29.0%) | -$16.00 M(+5.3%) |
| Sept 1997 | - | -$15.20 M(+6.3%) |
| June 1997 | - | -$14.30 M(+10.0%) |
| Mar 1997 | - | -$13.00 M |
| Dec 1996 | -$12.40 M | - |
FAQ
- What is Sarepta Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly retained earnings year-on-year change?
What is Sarepta Therapeutics annual retained earnings?
The current annual retained earnings of SRPT is -$4.45 B
What is the all time high annual retained earnings for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual retained earnings is -$12.40 M
What is Sarepta Therapeutics quarterly retained earnings?
The current quarterly retained earnings of SRPT is -$4.37 B
What is the all time high quarterly retained earnings for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly retained earnings is -$13.00 M
What is Sarepta Therapeutics quarterly retained earnings year-on-year change?
Over the past year, SRPT quarterly retained earnings has changed by +$76.19 M (+1.71%)